Laboratorios Farmaceuticos Rovi Stock Target Price
| LABFF Stock | USD 90.61 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratorios Farmaceuticos, as well as the relationship between them.
Laboratorios Farmaceuticos' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Laboratorios Farmaceuticos' valuation are provided below:Laboratorios Farmaceuticos Rovi does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Laboratorios |
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Laboratorios Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Shares Owned By Insiders | 60.25 % | |||
| Shares Owned By Institutions | 17.46 % | |||
| Price To Earning | 15.16 X | |||
| Price To Book | 6.51 X | |||
| Price To Sales | 3.45 X | |||
| Revenue | 648.68 M | |||
| Gross Profit | 379.83 M | |||
| EBITDA | 204.66 M | |||
| Net Income | 153.08 M | |||
| Cash And Equivalents | 158.94 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 1.77 X | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.37 X | |||
| Number Of Employees | 1.75 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 732.68 M | |||
| Z Score | 29.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 732.68 M |
About Laboratorios Farmaceuticos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratorios Farmaceuticos Rovi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratorios Farmaceuticos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratorios Farmaceuticos Rovi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Laboratorios Pink Sheet
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.